Smoking, Headaches And Allergies: Rx Pipeline Drugs May Impact OTCs
This article was originally published in The Tan Sheet
Executive Summary
Pfizer and Schering-Plough are developing a number of new prescription drugs and line extensions that could make inroads into large OTC categories